VivoSim Labs (VIVS) Debt Ratio (2024)
VivoSim Labs (VIVS) posted quarterly Debt Ratio of 0.09 for Q4 2024.
VivoSim Labs (VIVS) Debt Ratio (2024) Analysis & Trends
VivoSim Labs' Debt Ratio history runs 1 years deep, the most recent figure standing at 0.09 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | 0.47 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.09 |